Literature DB >> 11228341

Effects of alpha(2)-macroglobulin and antithrombin on thrombin generation and inhibition in cord and adult plasma.

G Cvirn1, S Gallistl, W Muntean.   

Abstract

Thromboembolic complications rarely occur during infancy and childhood. It has been reported that increased capacity of cord plasma to inhibit thrombin due to elevated alpha(2)-macroglobulin (alpha(2)-M) levels may in part provide protection from thrombosis. In antithrombin (AT)-deficient plasma, alpha(2)-M exhibits anticoagulant action by complexing substantial amounts of generated free thrombin. It has been suggested that alpha(2)-M has the same impact on thrombin inhibition as AT, the most important thrombin inhibitor in adult plasma. The aim of our study was to examine this assumption by determining time-courses of free thrombin generation and prothrombin activation. Additionally, the amount of thrombin complexed to alpha(2)-M was assessed by comparing the heights of the end-level of amidolytic activity curves (AACs) after extrinsic activation of platelet poor plasma in the presence of different concentrations of AT or alpha(2)-M. Increasing the AT content by 30% resulted in significantly suppressed generation of free thrombin and prothrombin fragment 1+2 (F1+2) in cord and adult plasma. In contrast, increasing the alpha(2)-M content in plasma containing physiologic amounts of AT by the same percentage had no effect on free thrombin generation and on F1+2 generation in both cord and adult plasma. In addition, the effect of AT supplementation on the end-level of the AACs was significantly higher compared to the effect of alpha(2)-M supplementation. Since alpha(2)-M, in contrast to AT, had no effect on free thrombin generation and prothrombin activation, our study suggests that the action between alpha(2)-M and thrombin might not be fast enough to prevent thrombin from its feedback activation in both cord and adult plasma and, therefore, in cord and adult plasma containing physiological amounts of AT alterations of the alpha(2)-M content had no effect on thrombin generation and inhibition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11228341     DOI: 10.1016/s0049-3848(00)00389-3

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  6 in total

1.  Inflammatory and metalloproteinases profiles predict three-month poor outcomes in ischemic stroke treated with thrombolysis.

Authors:  Anna Maria Gori; Betti Giusti; Benedetta Piccardi; Patrizia Nencini; Vanessa Palumbo; Mascia Nesi; Antonia Nucera; Giovanni Pracucci; Paolina Tonelli; Eleonora Innocenti; Alice Sereni; Elena Sticchi; Danilo Toni; Paolo Bovi; Mario Guidotti; Maria Rosaria Tola; Domenico Consoli; Giuseppe Micieli; Rossana Tassi; Giovanni Orlandi; Maria Sessa; Francesco Perini; Maria Luisa Delodovici; Maria Luisa Zedde; Francesca Massaro; Rosanna Abbate; Domenico Inzitari
Journal:  J Cereb Blood Flow Metab       Date:  2017-03-07       Impact factor: 6.200

2.  Alpha2-macroglobulin as a promising biomarker for cerebral small vessel disease in acute ischemic stroke patients.

Authors:  Tomohisa Nezu; Naohisa Hosomi; Shiro Aoki; Kazushi Deguchi; Hisashi Masugata; Noriko Ichihara; Hideo Ohyama; Toshiho Ohtsuki; Masakazu Kohno; Masayasu Matsumoto
Journal:  J Neurol       Date:  2013-07-23       Impact factor: 4.849

3.  Alpha-2-macroglobulin as a Promising Biological Marker of Endothelial Function.

Authors:  Ryo Shimomura; Tomohisa Nezu; Naohisa Hosomi; Shiro Aoki; Takamichi Sugimoto; Naoto Kinoshita; Mutsuko Araki; Tetsuya Takahashi; Hirofumi Maruyama; Masayasu Matsumoto
Journal:  J Atheroscler Thromb       Date:  2017-11-01       Impact factor: 4.928

4.  Draft genome sequences of Hirudo medicinalis and salivary transcriptome of three closely related medicinal leeches.

Authors:  Vladislav V Babenko; Oleg V Podgorny; Valentin A Manuvera; Artem S Kasianov; Alexander I Manolov; Ekaterina N Grafskaia; Dmitriy A Shirokov; Alexey S Kurdyumov; Dmitriy V Vinogradov; Anastasia S Nikitina; Sergey I Kovalchuk; Nickolay A Anikanov; Ivan O Butenko; Olga V Pobeguts; Daria S Matyushkina; Daria V Rakitina; Elena S Kostryukova; Victor G Zgoda; Isolda P Baskova; Vladimir M Trukhan; Mikhail S Gelfand; Vadim M Govorun; Helgi B Schiöth; Vassili N Lazarev
Journal:  BMC Genomics       Date:  2020-04-29       Impact factor: 3.969

5.  RNA-seq analysis and gene expression dynamics in the salivary glands of the argasid tick Ornithodoros erraticus along the trophogonic cycle.

Authors:  Ricardo Pérez-Sánchez; Ángel Carnero-Morán; Beatriz Soriano; Carlos Llorens; Ana Oleaga
Journal:  Parasit Vectors       Date:  2021-03-20       Impact factor: 3.876

6.  The influence of corn trypsin inhibitor on the contribution of coagulation determinants to the Technoclone Thrombin Generation Assay (TGA) and the Calibrated Automated Thrombogram (CAT).

Authors:  Carolina E Touw; Ype de Jong; Astrid van Hylckama Vlieg
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.